Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365398
Status:
COMPLETED
Last Update Posted:
2024-04-15
First Post:
2024-03-26
Brief Title:
Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Study Overview
Official Title:
Safety and Efficacy of Low-dose Heparinization in Cerebral Angiography a Randomized Controlled Study
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SELECT
Brief Summary:
Purpose Systemic heparinization is a widely used technique on digital subtraction angiography DSA Heparin however is associated with a variety of complications including hemorrhage thrombocytopenia and hematomas This study aimed to investigate the safety and efficacy of micro-dose systemic heparinization or no heparinization on cerebral angiography for cerebrovascular diseases
Methods A prospective single-blind randomized controlled study on patients who experienced transient ischemic attacks TIAs or acute ischemic strokes and underwent DSA is performed Participants are randomized into three groups regular-dose systemic heparinization micro-dose systemic heparinization and no heparinization Information on patient demographics laboratory tests perioperative complications and back pain scores is collected Safety endpoints are defined as cerebral ischemic events and local complications of puncture site Efficacy endpoints were defined as the recovery of the patients
Methods A prospective single-blind randomized controlled study on patients who experienced transient ischemic attacks TIAs or acute ischemic strokes and underwent DSA is performed Participants are randomized into three groups regular-dose systemic heparinization micro-dose systemic heparinization and no heparinization Information on patient demographics laboratory tests perioperative complications and back pain scores is collected Safety endpoints are defined as cerebral ischemic events and local complications of puncture site Efficacy endpoints were defined as the recovery of the patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| XWHL-2018010 | OTHER_GRANT | Xuanwu Hospital Capital Medical University | None |